Sign Up to our Newsletter
ABOUT THE SUMMIT
The North American Biocompatibility Summit (NABS) is a limited-seating event that provides industry insights and expertise sharing on the biocompatibility of medical devices. Sessions include the latest regulatory updates, biological evaluation strategies and best practices that lead to successful biocompatibility programs.
Led by the medical device industry’s foremost biological safety experts, speakers will address:
- Regulatory strategies and how they relate to ISO 10993
- New and innovative biocompatibility methods and technologies
- The relationship between material/chemical characterization and biocompatibility testing
- Toxicology and risk management
- Industry case studies
Join us for this one day exclusive summit to learn and network with top scientists, toxicologists, and industry leaders in the medical device biocompatibility field!
Should you have any questions, please contact Céline Puleo, Global Marketing Event Manager, cpuleo@namsa.com.
REGISTER NOW!
Call for Abstracts
The dynamic landscape of biocompatibility presents unique challenges across different regions. The upcoming Summit is the perfect platform to address these issues, share best practices, and explore advocacy efforts aimed at easing regulatory pressures on manufacturers.
We are seeking submissions from Toxicologists, Scientists, and industry leaders specializing in biocompatibility. Following last year’s success, the NABS Scientific Board is eager to maintain a focus on global hurdles of chemical characterization and biocompatibility for the 2025 agenda. (All accepted abstracts/speakers will receive a complimentary pass to this limited seating event.)
To submit your abstract, please click here. Abstracts submitted without a detailed description and objectives will not be considered. The deadline for submissions is June 8, 2025.
For inquiries about abstract submission, please contact Sheri Krajewski at: sbibins@namsa.com.
2024 Summit Schedule
8:00 – 8:45 AM



8:45 – 10:15 AM



10:15 – 10:45 AM



10:45 – 11:30 AM



11:30 AM – 12:30 PM



12:30 – 2:45 PM



2:45- 3:15 PM



3:15 – 4:45 PM



4:45 – 6:00 PM



Past Summit Topics

Biological Safety of Aged e-PTFE Vascular Grafts and Components: Significance of Materials
Characterization, E&L Analysis and Toxicological Risk Assessments

Medical Device Sensitization Update: ISO Standards, In Vitro Testing and Quantitative Risk Assessments

Beyond "Paper" Exercises: How Strategic Information Gathering Results in Superior E&L Outcomes

Estimating the Polarity of Drug Formulations for the Selection of Extraction Solvents

Chemical Characterization Best Practices: Assumptions of TTC and Exhaustive Extraction

Small Change, Big Impact: A Chemical Characterization Case Study
The Need for Exhaustive Extraction of Medical Devices: Thoughts from a Toxicological Risk Assessment Perspective

Analytical Evaluation Threshold: Practical Implementation and Regulatory Considerations
If you are interested in Sponsorship Opportunities, please contact Céline Puleo, Global Marketing Event Manager, at cpuleo@namsa.com.
- Presenting Sponsorship (Sold Out) – $3,500
- Gold Sponsorship (2 Available) – $2,500
- Silver Sponsorship (2 Available) – $1,500
- Bronze Sponsorship (Multiple Available) – $750
EVENT LOCATION
Quincy Hall
1325 Quincy St. NE
Minneapolis, Minn. 55413
Tel: 612-400-1754
As a global leader in medical device innovation, Minneapolis is a perfect location for this summit addressing one of the hottest topics in the medical device industry today.
Due to limited seating, the number of attendees will ensure you will have the opportunity to personally connect and network with fellow attendees, speakers, and event sponsors.
Questions About The Event?
Feel free to contact us should you have any questions about the
North American Biocompatibility Summit.